Skip to main content
logo
Purple Biotech Ltd (TLV:PPBT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.000
0.00 (0.00%)
Jul 27, 2026, 5:24 PM IDT

Purple Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-0.06-0.06-0.06-0.2-0.12-0.06
Operating Income
-7.82-6.98-10.8-22.27-22.6-17.92
Net Income
-26.02-26.39-7.24-19.88-21.67-18.38
Earnings Per Share
-0.02-0.03-0.02-0.09-0.12-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.439.578.5215.4132.1147.2
Total Debt
0.180.240.180.350.520.75
Net Cash (Debt)
6.249.338.3415.0631.646.45
Net Cash Growth
-10.19%11.86%-44.62%-52.34%-31.98%-18.38%
Net Cash Per Share
0.000.010.030.070.170.26

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.8-5.66-14.37-19.93-16.74-15.25
Capital Expenditures
-0-0--0-0.03-0.12
Free Cash Flow
-6.8-5.66-14.37-19.93-16.76-15.37
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------